ArticlePloS one2025
Cell-free DNA screening for trisomies 21, 18, and 13: Clinical application and accuracy evaluation.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alpha-Fetoprotein as a Biomarker in Pregnancy: From Genetic Disorders to Obstetric Complications.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCell-free DNA (cf-DNA) screening for common trisomies has been increasingly assimilated into prenatal care. In this study, we evaluated the Z-score accuracy and the effectiveness of non-invasive prenatal testing (NIPT) for trisomies 21, 18, and 13 using cf-DNA, and further analyze pregnancy outcomes of NIPT-positive pregnant women.
methodsThis retrospective study analyzed pregnancies that yielded positive NIPT results at Shaoxing Maternity and Child Health Care Hospital between 01/01/2017 and 31/12/2022. Invasive prenatal diagnosis (IPD) confirmed the positive NIPT findings. Logistic regression analysis was applied to correlation analysis of Z-scores and positive predictive value (PPV). Accuracy of Z-score was evaluated through receiver operating characteristic (ROC) curve analysis. Data regarding basic characteristics, prenatal diagnosis results, and pregnancy outcomes were collected.
resultsIn total,257 high-risk cases of trisomy 21, 18, and 13 were identified. Among these,193 pregnancies underwent invasive prenatal diagnosis (IPD) in our institution, the PPV was 75.44% for T21,45.28% for T18, and 17.86% for T13. A significant association between Z-scores and PPVs were revealed by logistic regression(p < 0.05). The ROC curve analysis revealed optimal cutoff values of 7.231 for T21, 5.245 for T18, and 7.504 for T13. The corresponding areas under the curve (AUC) were 0.954, 0.941, and 0.924, respectively. Moreover, the PPV was statistically higher in the very-high-risk (VHR) group than in the general high-risk (GHR) group. In terms of pregnancy outcomes,98.51% (132/134) of pregnancies identified with chromosomal abnormalities were terminated, whereas 98.89% (89/90) of those diagnosed with false-positive results were carried to term.
conclusionsThe study demonstrates that the Z-score is valuable in accurately assessing NIPT results. Consequently, clinicians can provide more efficient prenatal genetic counseling by utilizing a specific reference value for the Z-score.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.